Selected article for: "effective treatment and pneumonia death"

Author: Boulkrane, Mohamed Said; Ilina, Victoria; Melchakov, Roman; Fedotova, Julia; Drago, Filippo; Gozzo, Lucia; Das, Undurti Narasimha; Abd El-Aty, A. M.; Baranenko, Denis
Title: COVID-19 Disease and Vitamin D: A Mini-Review
  • Cord-id: ki0ydedm
  • Document date: 2020_12_17
  • ID: ki0ydedm
    Snippet: Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 virus/COVID-19 disease. Vitamin D is well-known to play a significant role in maintaining the immune health of an individual. Moreover, it induces antimicrobial peptide expression that can decrease viral
    Document: Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 virus/COVID-19 disease. Vitamin D is well-known to play a significant role in maintaining the immune health of an individual. Moreover, it induces antimicrobial peptide expression that can decrease viral replication and regulate the levels of pro-inflammatory/anti-inflammatory cytokines. Therefore, supplementation of vitamin D has the potential to reduce the incidence, severity and the risk of death from pneumonia resulting from the cytokine storm of many viral infections including COVID-19. We suggest that supplementation of subjects at high risk of COVID-19 with vitamin D (1.000 to 3.000 IU) to maintain its optimum serum concentrations may be of significant benefit for both in the prevention and treatment of the COVID-19.

    Search related documents:
    Co phrase search for related documents
    • activation proliferation and acute lung injury: 1
    • activation proliferation and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • activation proliferation and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • activation proliferation and adaptive immune response: 1, 2
    • activation proliferation and adaptive immune response innate: 1
    • activation proliferation and low concentration: 1
    • activation regulate and acute ards respiratory distress syndrome: 1
    • activation regulate and acute respiratory: 1, 2, 3, 4, 5, 6, 7
    • activation regulate and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • activation regulate and adaptive immune response: 1
    • activation regulate and adaptive immune response innate: 1
    • activation regulate and adaptive immune system: 1
    • active metabolite and acute ards respiratory distress syndrome: 1, 2, 3
    • active metabolite and acute lung injury: 1, 2
    • active metabolite and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • active metabolite and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • active metabolite and loading dose: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and adaptive immune response innate: 1, 2, 3, 4, 5, 6, 7